Key result
Integrating multi-omics technologies enables a comprehensive examination of the platelet proteome, lipidome, and metabolome to advance therapeutic strategies for platelet-related disorders.
Why the study?
Integrating multi-omics approaches is needed to provide a holistic understanding of complex mechanisms underpinning platelet function and dysfunction in bleeding disorders and cardiovascular diseases.
Integrating multi-omics technologies provides a comprehensive understanding of platelet biology, which is crucial for advancing therapeutic strategies and diagnostic tools for cardiovascular diseases.
Provides a framework for understanding platelet-mediated cardiovascular risk; leaves open the translation of these.
Platelets, tiny cell fragments measuring 2-4 μm in diameter without a nucleus, play a crucial role in blood clotting and maintaining vascular integrity. Abnormalities in platelets, whether genetic or acquired, are linked to bleeding disorders, increased risk of blood clots, and cardiovascular diseases. Advanced proteomic techniques offer profound insights into the roles of platelets in hemostasis and their involvement in processes such as inflammation, metastasis, and thrombosis. This knowledge is vital for drug development and identifying diagnostic markers for platelet activation. Platelet activation is an exceptionally rapid process characterized by various posttranslational modifications, including protein breakdown and phosphorylation. By utilizing multiomics technologies and biochemical methods, researchers can thoroughly investigate and define these posttranslational pathways. The absence of a nucleus in platelets significantly simplifies mass spectrometry-based proteomics and metabolomics, as there are fewer proteins to analyze, streamlining the identification process. Additionally, integrating multiomics approaches enables a comprehensive examination of the platelet proteome, lipidome, and metabolome, providing a holistic understanding of platelet biology. This multifaceted analysis is critical for elucidating the complex mechanisms underpinning platelet function and dysfunction. Ultimately, these insights are crucial for advancing therapeutic strategies and improving diagnostic tools for platelet-related disorders and cardiovascular diseases. The integration of multi-omics technologies is paving the way for a deeper understanding of platelet mechanisms, with significant implications for biomedical research and clinical applications.
No takes yet. Share an insight, caveat, or question.
Fareed et al. (2025) conducted a review in Platelet-related disorders and cardiovascular diseases. Multi-omics integration was evaluated. Integrating multi-omics technologies enables a comprehensive examination of the platelet proteome, lipidome, and metabolome to advance therapeutic strategies for platelet-related disorders.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: